Main > ONCOLOGY (**) > Skin Cancer>DFSP>MET R *** > Treatment > Co: CH. N. Brand Imatinib>

---

Co: CH. N. Brand Imatinib>'s subsections
(*) USA Approval Date: 2006. 11.01
>Unresectable
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Expiration Date: 2015. 01.04
Patent>Total USA No.: 3
Patent>UpDate: 2007. 01.23.
TradeMark (USA)
TradeMark (USA) Web-Site
UpDate: 2016. 07.06.

Co: CH. N. Brand Imatinib>'s products
This section has no products